Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > New technology, ‘Invasion-Block’, targets melanoma spread

New technology, ‘Invasion-Block’, targets melanoma spread

Date time 22 November, 2023
News Type News type Media release
Dr Shweta Tikoo and Dr Dajiang Guo
Research conducted at the Centenary Institute has given rise to a ground-breaking tool called 'Invasion-Block' that can identify drugs capable of halting the spread of cancer cells. The pioneering development could lead to better treatments for melanoma, the most dangerous form of skin cancer.

An automated high-content screening platform, ‘Invasion-Block’ is designed to measure the invasive capacity of cancer cells. A revolutionary tool, it enables scientists to assess how well various drugs and compounds can prevent the spread of cancer.

In the recently published study, ‘Invasion-Block’ was employed to investigate the invasive behaviour of melanoma cells, particularly their ability to infiltrate other parts of the body. It was used in conjunction with a custom-designed image analysis program called ‘S-MARVEL’, to screen thousands of compounds, including drugs that are already approved for use in people.

Dr Shweta Tikoo, senior study researcher affiliated with both the Centenary Institute and the Department of Dermatology, Medical University of Vienna said that melanoma is an extremely challenging disease.

“Melanoma is a tough opponent, often spreading rapidly and making it difficult to treat. The key to finding better treatments lies in drug discovery and this is where the ‘Invasion-Block’ tool plays a pivotal role,” said Dr Tikoo.

Excitingly for the researchers, ‘Invasion Block’ revealed that drugs that blocked a class of enzymes – known as Abl/Src, PKC, PI3K, and ATM kinases – made melanoma cells much less able to invade other tissues.

“This suggests these enzymes may hold the key to finding treatments that can help curb the spread of melanoma,” said Dr Dajiang Guo, the first author of the study, currently a postdoctoral researcher at the Weill Cornell Medicine.

Intriguingly, the researchers further used CRISPR technology to ‘turn-off’ the gene responsible for expressing ATM kinase in melanoma cells. In doing so they observed that the melanoma cells became less invasive in laboratory tests and didn’t spread as much to the lymph nodes when tested in mice.

“We believe that ATM may serve as a potent therapeutic target for treating the spread of melanoma in patients,” said Dr Tikoo.

The researchers say the study is a significant step in the fight against melanoma, offering fresh hope to patients while laying the groundwork for further studies and the development of new and better treatments.

“The combination of ‘Invasion-Block’ and ‘S-MARVEL’ is opening new avenues in the search for drugs that can arrest the spread of cancer,” said Dr Tikoo.

The study was co-headed by Dr Rohit Jain, Professor Wolfgang Weninger and Dr Shweta Tikoo with all three senior authors being co-affiliated with the Centenary Institute and the Medical University of Vienna.

The research was published in The Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences.

Themes

  • Cancer Innovations

    Cancer Innovations

Media enquires

For all media and interview enquiries, please contact Alison Mendel

Phone number Phone Number +61 434 629 469

Email Email a.mendel@centenary.org.au

Media Release

New technology, 'Invasion-Block', targets melanoma spread

Download

Recent Stories

  • New platform to evolve proteins for better therapies

    Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.
    News Type: Media release
    Date 08 May 2025
  • Turning off protein may help prevent liver cancer

    New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer.
    News Type: Media release
    Date 16 Apr 2025
  • Event shines spotlight on genetic heart disease in young people

    The Centenary Institute has hosted a community event, titled ‘A Needle in a Haystack: Unlocking the Secrets of Genetic Heart Conditions’. The event aimed to advance understanding of inherited heart disease and sudden cardiac death in young people.
    News Type: Community
    Date 10 Apr 2025
  • Finding answers for sudden cardiac death in young people

    Each week in Australia, up to three young people die suddenly and unexpectedly from sudden cardiac death, often due to an undiagnosed genetic heart condition. These conditions typically go unnoticed until tragedy strikes, leaving families devastated and searching for answers.
    News Type: Media release
    Date 02 Apr 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram